You are here: Home Recent Publications

Recent Publications

complete bibliography of published works: States, JC, Barchowsky, A, Cartwright, IL, Reichard, JF, Futscher, BW, Lantz, RC. Arsenic Toxicology: Translating between Experimental Models and Human Pathology. Environ Health Perspect. 119:1356-63 (2011). Muenyi CS, States VA, Masters JH, Fan TW, Helm CW, States JC. Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC). J Ovarian Res. Jun 22; 4:9 (2011). Millner LM, Doll MA, Cai J, States JC, Hein DW. NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl. Mol Carcinog.51:636-46 (2012). Tan M, Schmidt RH, Beier JI, Watson WH, Zhong H, States JC, Arteel GE. Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. Toxicol Appl Pharmacol. 257:356-364, 2011 Millner LM, Doll MA, Cai J, States JC, Hein DW. Phenotype of the Most Common "Slow Acetylator" Arylamine N-Acetyltransferase 1 Genetic Variant (NAT1*14B) is Substrate-Dependent. Drug Metab Dispos. 40:198-204 (2012). Millner LM, Doll MA, Stepp MW, States JC, Hein DW. Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct. Carcinogenesis 33:348-55 (2012). Muenyi CS, Pinhas AR,. Fan TW, Brock GN, Helm CW, States JC. Sodium arsenite ± hyperthermia sensitizes p53 expressing human ovarian cancer cells to cisplatin by modulating platinum DNA damage responses. Toxicological Sciences 27:139-49 (2012). Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lillycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM. Predicting later-life outcomes of early-life exposures. Environ Health Perspect. 120: 1353-1361 (2012) States JC, Singh AV, Knudsen TB, Rouchka EC, Ngalame NO, Arteel GE, Piao Y, Ko MS. Prenatal Arsenic Exposure Alters Gene Expression in the Adult Liver to a Proinflammatory State Contributing to Accelerated Atherosclerosis. PLoS ONE 7(6): e38713 (2012). doi:10.1371/journal.pone.0038713 Das N, Paul S, Chatterjee D, Banerjee N, Majumder NS, Sarma N, Sau TJ, Basu S, Banerjee S, Majumder P, Bandyopadhyay AK, States JC, Giri AK. Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India. BMC Public Health. 12:639 (2012) doi: 10.1186/1471-2458-12-639. Ngalame N, Micciche A, Feil M, States JC. Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. Toxicol Sci. 131: 225-233 (2013) Muenyi, CS, Pandit, A, Helm, CW, States, JC. Cisplatin Plus Sodium Arsenite And Hyperthermia Induces Pseudo-G1 Associated Apoptotic Cell Death In Ovarian Cancer Cells. Toxicological Sciences 139:74-82 (2014) States, JC, Ouyang, M, Helm, CW. Systems Approach to Identify Environmental Exposures Contributing to Organ-Specific Carcinogenesis. Cancer Epidemiology 38:321-327 (2014) Wahlang B, Falkner KC, Clair HB, Al-Eryani L, Prough RA, States JC, Coslo DM, Omiecinski CJ, Cave MC. Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. Toxicological Sciences 140:283-297 (2014). Wahlang B, Song M2 Beier JI, Cameron Falkner K, Al-Eryani L, Clair HB, Prough RA, Osborne TS, Malarkey DE, States JC, Cave MC. Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease. Toxicol Appl Pharmacol. 279:380-90 (2014). States JC. Disruption of Mitotic Progression by Arsenic. Biological Trace Elements in Research (2015) DOI: 10.1007/s12011-015-0306-7 [] (in press)

Document Actions
Personal tools